157 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B Downtrend
Article Searches
Company News For Jan 30, 2018 http://www.zacks.com/stock/news/290592/company-news-for-jan-30-2018?cid=CS-ZC--290592 Jan 30, 2018 - Companies In The News are: LMT,DPS,CYOU,ABLYF,SNY,NVO
Sanofi on a Buyout Spree This Month, to Buy Ablynx for $4.8B http://www.zacks.com/stock/news/290580/sanofi-on-a-buyout-spree-this-month-to-buy-ablynx-for-%2448b?cid=CS-ZC-FT-290580 Jan 30, 2018 - Sanofi (SNY) to acquire Ablynx for EUR 3.9 billion to expand its late stage pipeline and strengthen rare blood disorder growth platform.
AbbVie (ABBV) Soars on Q4 Results: Key Takeaways from the Earnings Call http://www.zacks.com/stock/news/290323/abbvie-abbv-soars-on-q4-results-key-takeaways-from-the-earnings-call?cid=CS-ZC-FT-290323 Jan 29, 2018 - With AbbVie (ABBV) surpassing expectations in the fourth quarter, here's a look at a few important takeaways from the company's conference call.
AbbVie (ABBV) Q4 Earnings Beat, 2018 View Raised, Shares Up http://www.zacks.com/stock/news/290293/abbvie-abbv-q4-earnings-beat-2018-view-raised-shares-up?cid=CS-ZC-FT-290293 Jan 26, 2018 - AbbVie's (ABBV) Q4 earnings top estimates with revenues marginally beating the same. Sales of the company's lead marketed drug, Humira, also rise year over year.
Will Sanofi's Big Hemophilia Deal Pay Off? https://www.fool.com/investing/2018/01/24/will-sanofis-big-hemophilia-deal-pay-off.aspx?source=iedfolrf0000001 Jan 24, 2018 - Sanofi's leap into an undeniably big market could face challenges as treatment evolves.
Biotech M&A Off to a Strong Start in 2018: More Deals to Follow? http://www.zacks.com/stock/news/289649/biotech-ma-off-to-a-strong-start-in-2018-more-deals-to-follow?cid=CS-ZC-FT-289649 Jan 23, 2018 - Does Celgene's (CELG) decision to acquire Juno signal the revival of biotech M&A activity after a slow 2017?
Better Buy: GlaxoSmithKline plc vs. Eli Lilly https://www.fool.com/investing/2018/01/21/better-buy-glaxosmithkline-plc-vs-eli-lilly.aspx?source=iedfolrf0000001 Jan 21, 2018 - Both big pharma stocks have growth drivers. But both also come with baggage.
The Zacks Analyst Blog Highlights: Johnson & Johnson, AbbVie, Amgen, Novo-Nordisk and Zoetis http://www.zacks.com/stock/news/289410/the-zacks-analyst-blog-highlights-johnson-johnson-abbvie-amgen-novo-nordisk-and-zoetis?cid=CS-ZC-FT-289410 Jan 19, 2018 - The Zacks Analyst Blog Highlights: Johnson & Johnson, AbbVie, Amgen, Novo-Nordisk and Zoetis
Can These 4 Large-Cap Drug Stocks Deliver an Encore in '18? http://www.zacks.com/stock/news/289345/can-these-4-large-cap-drug-stocks-deliver-an-encore-in-18?cid=CS-ZC-FT-289345 Jan 18, 2018 - We present four large cap drug companies, which are expected to repeat their last year's industry beating performance in 2018.
Is Eli Lilly and Company a Buy in 2018? https://www.fool.com/investing/2018/01/17/is-eli-lilly-and-company-a-buy-in-2018.aspx?source=iedfolrf0000001 Jan 17, 2018 - The outlook is complicated for this big pharma stock.

Pages: 1...345678910111213...16

<<<Page 8>